Pay in 4 interest-free payments of $7.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
glp-1 insurance How Many Adults with Private Health Could Use Drugs Quantity:3 Months Do I have to peptide laboratory use only
Do I have to take a GLP-1 forever? Probably. Same as blood pressure. Stop the pill, the number climbs back. Obesity is a chronic disease. Stop treatment and it progresses. Full breakdown
Jay explains how fixed employer contributions can make GLP-1 benefits more predictable, why he believes prior authorizations add unnecessary costs, and what patients can do when their coverage is at risk.They also discuss Medicare access, losing coverage after successful weight loss, options for self-employed people, compounded medications, future GLP-1 competition, and whether access can become more equitable.**IN THIS EPISODE**- Why GLP-1 demand creates problems for traditional insurance- How pharmaceutical middlemen affect medication pricing and access- What direct-to-employer purchasing means- Why employers hesitate to fund open-ended GLP-1 coverage- How fixed employer contributions could make benefits more sustainable- Why successful treatment and a lower BMI can lead to lost coverage- The hidden administrative costs of prior authorizations- What to do if you’re worried about affording your medication- Options for self-employed people without employer assistance- Jay’s perspective on Medicare, compounded medications, competition, and equitable access**ABOUT THE GUEST**Jay Bregman is the founder and CEO of Andel, a healthcare technology platform that enables high-cost medications like GLP-1s to be more accessible through employer benefits
peptide laboratory use only
Quantity:3 Months
[DOI] [PubMed] [Google Scholar] 35.Shah M, Vella A
US$ 28.87
US$ 20.34
US$ 21.33